AQR Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.66M | Buy |
125,450
+63,351
| +102% | +$4.37M | 0.01% | 1024 |
|
|
2025
Q1 | $4.31M | Buy |
62,099
+10,758
| +21% | +$747K | ﹤0.01% | 1202 |
|
|
2024
Q4 | $4.42M | Buy |
51,341
+353
| +0.7% | +$30.4K | 0.01% | 1158 |
|
|
2024
Q3 | $6.07M | Buy |
50,988
+33,824
| +197% | +$4.03M | 0.01% | 969 |
|
|
2024
Q2 | $2.45M | Buy |
17,164
+9,012
| +111% | +$1.29M | ﹤0.01% | 1368 |
|
|
2024
Q1 | $1.05M | Buy |
8,152
+2,990
| +58% | +$384K | ﹤0.01% | 1669 |
|
|
2023
Q4 | $534K | Sell |
5,162
-133
| -3% | -$13.8K | ﹤0.01% | 1850 |
|
|
2023
Q3 | $482K | Buy |
+5,295
| New | +$482K | ﹤0.01% | 1859 |
|